• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alnylam Pharmaceuticals Inc

+ Add to Watchlist

ALNY:US

55.8799 USD 0.5499 0.99%

As of 10:17:54 ET on 07/30/2014.

Snapshot for Alnylam Pharmaceuticals Inc (ALNY)

Open: 56.0700 Day's Range: 55.4600 - 57.1200 Volume: 67,725
Previous Close: 55.3300 52wk Range: 44.7600 - 112.5700 1-Yr Rtn: +22.08%

Stock Chart for ALNY

No chart data available.
  • ALNY:US 55.7900
  • 1D
  • 1M
  • 1Y
55.3300
Interactive ALNY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.8273
Est. EPS (USD) (12/2014) -3.6350
Est. PEG Ratio -
Market Cap (M USD) 4,260.46
Shares Outstanding (M) 75.55
30 Day Average Volume 815,682
Price/Book (mrq) 4.4138
Price/Sale (ttm) 96.3703
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALNY

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.

John M MaraganoreChief Executive OfficerBarry E GreenePresident/COO
Akshay K VaishnawExec VP/Chief Medical OfficerLaurence E ReidSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for ALNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil